These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30380975)

  • 21. Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines.
    Lepage P; Vergison A
    Expert Opin Biol Ther; 2007 Dec; 7(12):1881-92. PubMed ID: 18034653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.
    Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F
    Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of rotavirus vaccination on acute diarrhea in Thai children under 5 years of age in the first year of universal implementation of rotavirus vaccines in the National Immunization Program (NIP) in Thailand: a 6-year analysis.
    Charoenwat B; Suwannaying K; Paibool W; Laoaroon N; Sutra S; Thepsuthammarat K; Sirirattanakul S
    BMC Public Health; 2023 Oct; 23(1):2109. PubMed ID: 37891542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option.
    Cui S; Tobe RG; Mo X; Liu X; Xu L; Li S
    BMC Infect Dis; 2016 Nov; 16(1):677. PubMed ID: 27846803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.
    Chang WC; Yen C; Wu FT; Huang YC; Lin JS; Huang FC; Yu HT; Chi CL; Lin HY; Tate JE; Parashar UD; Wu HS; Hsiung CA
    Pediatr Infect Dis J; 2014 Mar; 33(3):e81-6. PubMed ID: 24569388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance.
    Calnan M; Krishnarajah G; Duh MS; Haider BA; Yermakov S; Davis M; Yan S
    Hum Vaccin Immunother; 2016 May; 12(5):1235-43. PubMed ID: 26900728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.
    Kirkwood CD; Boniface K; Barnes GL; Bishop RF
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S48-53. PubMed ID: 21183840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.
    Mwenda JM; Burke RM; Shaba K; Mihigo R; Tevi-Benissan MC; Mumba M; Biey JN; Cheikh D; Poy MSc A; Zawaira FR; Aliabadi N; Tate JE; Hyde T; Cohen AL; Parashar UD
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1192-1196. PubMed ID: 29095805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.
    Burnett E; Lopman BA; Parashar UD
    Vaccine; 2017 Dec; 35(51):7198-7203. PubMed ID: 29169893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People's Democratic Republic.
    Rheingans R; Anderson JD; Bagamian KH; Pecenka CJ
    Vaccine; 2018 Dec; 36(51):7868-7877. PubMed ID: 30007827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.
    Wang FT; Mast TC; Glass RJ; Loughlin J; Seeger JD
    Pediatr Infect Dis J; 2013 Mar; 32(3):278-83. PubMed ID: 23014356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial.
    Zaman K; Sack DA; Neuzil KM; Yunus M; Moulton LH; Sugimoto JD; Fleming JA; Hossain I; Arifeen SE; Azim T; Rahman M; Lewis KDC; Feller AJ; Qadri F; Halloran ME; Cravioto A; Victor JC
    PLoS Med; 2017 Apr; 14(4):e1002282. PubMed ID: 28419095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public health impact and cost-effectiveness of rotavirus vaccination in China: Comparison between private market provision and national immunization programs.
    Wang J; Zhang H; Zhang H; Fang H
    Hum Vaccin Immunother; 2022 Dec; 18(7):2090162. PubMed ID: 35816415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of different dosing schedules of the human live attenuate rotavirus vaccine (RV1) in infants and children: a meta-analysis.
    Dai X; Bai R; Jian M; Ji Z; Ding Z; Wang F; Bi Y; Manzamaesso A; Chen T; Luo L; Liu A; Bao F
    Hum Vaccin Immunother; 2019; 15(6):1228-1236. PubMed ID: 30346870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial.
    Rongsen-Chandola T; Winje BA; Goyal N; Rathore SS; Mahesh M; Ranjan R; Arya A; Rafiqi FA; Bhandari N; Strand TA
    Trials; 2014 Jun; 15():256. PubMed ID: 24976452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.